检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]第二军医大学流行病学教研室,上海200433
出 处:《上海预防医学》2017年第4期253-256,共4页Shanghai Journal of Preventive Medicine
基 金:国际合作与交流项目(81520108021);国家重点基础研究发展计划(2015CB554000)
摘 要:肝细胞癌(HCC)是世界最主要的恶性肿瘤类型之一,其中近50%的患者集中在中国。HCC属于男性高发癌症,流行病学数据显示,我国HCC发病率男女比例为2∶1~5∶1。目前发现可能导致HCC性别差异性的危险因素包括:乙型肝炎病毒感染和突变、免疫遗传易感性以及性激素受体作用。相关研究不仅有助于阐明HCC进化发育的具体生物学过程,更揭示了HCC发生和预后与性别差异相关的生物学标志,对完善HCC防控策略具有重要意义。Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. About 50% of the total number of HCC cases and deaths worldwide occurred in China. Male has high incidence rates of HCC. Epidemiological data showed that ratio between the male incidence of HCC and the female incidence was from 2:1 to 5:1 in China. Up to now, risk factors found to be able to give rise to the sexual dimorphism in HCC incidences include infection and mutation of hepatitis B virus, immune genetic susceptibility and functions of hormone receptors. Relevant studies can not only help clarify the specific biological processes of hepatocarcinogenesis, but also uncover the biological indications that associate the incidences and prognoses of HCC with the sexual dimorphism, thus playing an important role in improving the strategies of control and prevention.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117